Influenza NA Inhibitor Market
1 Study Coverage
1.1 Influenza NA Inhibitor Product Introduction
1.2 Market by Type
1.2.1 Global Influenza NA Inhibitor Market Size Growth Rate by Type
1.2.2 Zanamivir
1.2.3 Oseltamivir
1.2.4 Peramivir
1.3 Market by Application
1.3.1 Global Influenza NA Inhibitor Market Size Growth Rate by Application
1.3.2 Influenza A Treatment
1.3.3 Influenza B Treatment
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza NA Inhibitor Market Size, Estimates and Forecasts
2.1.1 Global Influenza NA Inhibitor Revenue 2016-2027
2.1.2 Global Influenza NA Inhibitor Sales 2016-2027
2.2 Global Influenza NA Inhibitor, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Influenza NA Inhibitor Historical Market Size by Region (2016-2021)
2.3.1 Global Influenza NA Inhibitor Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Influenza NA Inhibitor Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Influenza NA Inhibitor Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Influenza NA Inhibitor Sales Forecast by Region (2022-2027)
2.4.2 Global Influenza NA Inhibitor Revenue Forecast by Region (2022-2027)
3 Global Influenza NA Inhibitor Competitor Landscape by Players
3.1 Global Top Influenza NA Inhibitor Manufacturers by Sales
3.1.1 Global Influenza NA Inhibitor Sales by Manufacturer (2016-2021)
3.1.2 Global Influenza NA Inhibitor Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Influenza NA Inhibitor Manufacturers by Revenue
3.2.1 Key Influenza NA Inhibitor Manufacturers Covered: Ranking by Revenue
3.2.2 Global Influenza NA Inhibitor Revenue by Manufacturers (2016-2021)
3.2.3 Global Influenza NA Inhibitor Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Influenza NA Inhibitor Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Influenza NA Inhibitor Revenue in 2020
3.2.6 Global Influenza NA Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Influenza NA Inhibitor Price by Manufacturers
3.4 Global Influenza NA Inhibitor Manufacturing Base Distribution, Product Types
3.4.1 Influenza NA Inhibitor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza NA Inhibitor Product Type
3.4.3 Date of International Manufacturers Enter into Influenza NA Inhibitor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Influenza NA Inhibitor Market Size by Type (2016-2021)
4.1.1 Global Influenza NA Inhibitor Sales by Type (2016-2021)
4.1.2 Global Influenza NA Inhibitor Revenue by Type (2016-2021)
4.1.3 Influenza NA Inhibitor Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Influenza NA Inhibitor Market Size Forecast by Type (2022-2027)
4.2.1 Global Influenza NA Inhibitor Sales Forecast by Type (2022-2027)
4.2.2 Global Influenza NA Inhibitor Revenue Forecast by Type (2022-2027)
4.2.3 Influenza NA Inhibitor Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Influenza NA Inhibitor Market Size by Application (2016-2021)
5.1.1 Global Influenza NA Inhibitor Sales by Application (2016-2021)
5.1.2 Global Influenza NA Inhibitor Revenue by Application (2016-2021)
5.1.3 Influenza NA Inhibitor Price by Application (2016-2021)
5.2 Influenza NA Inhibitor Market Size Forecast by Application (2022-2027)
5.2.1 Global Influenza NA Inhibitor Sales Forecast by Application (2022-2027)
5.2.2 Global Influenza NA Inhibitor Revenue Forecast by Application (2022-2027)
5.2.3 Global Influenza NA Inhibitor Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Influenza NA Inhibitor Market Size YoY Growth 2016-2027
6.1.1 Japan Influenza NA Inhibitor Sales YoY Growth 2016-2027
6.1.2 Japan Influenza NA Inhibitor Revenue YoY Growth 2016-2027
6.1.3 Japan Influenza NA Inhibitor Market Share in Global Market 2016-2027
6.2 Japan Influenza NA Inhibitor Market Size by Players (International and Local Players)
6.2.1 Japan Top Influenza NA Inhibitor Players by Sales (2016-2021)
6.2.2 Japan Top Influenza NA Inhibitor Players by Revenue (2016-2021)
6.3 Japan Influenza NA Inhibitor Historic Market Review by Type (2016-2021)
6.3.1 Japan Influenza NA Inhibitor Sales Market Share by Type (2016-2021)
6.3.2 Japan Influenza NA Inhibitor Revenue Market Share by Type (2016-2021)
6.3.3 Japan Influenza NA Inhibitor Price by Type (2016-2021)
6.4 Japan Influenza NA Inhibitor Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Influenza NA Inhibitor Sales Forecast by Type (2022-2027)
6.4.2 Japan Influenza NA Inhibitor Revenue Forecast by Type (2022-2027)
6.4.3 Japan Influenza NA Inhibitor Price Forecast by Type (2022-2027)
6.5 Japan Influenza NA Inhibitor Historic Market Review by Application (2016-2021)
6.5.1 Japan Influenza NA Inhibitor Sales Market Share by Application (2016-2021)
6.5.2 Japan Influenza NA Inhibitor Revenue Market Share by Application (2016-2021)
6.5.3 Japan Influenza NA Inhibitor Price by Application (2016-2021)
6.6 Japan Influenza NA Inhibitor Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Influenza NA Inhibitor Sales Forecast by Application (2022-2027)
6.6.2 Japan Influenza NA Inhibitor Revenue Forecast by Application (2022-2027)
6.6.3 Japan Influenza NA Inhibitor Price Forecast by Application (2022-2027)
7 North America
7.1 North America Influenza NA Inhibitor Market Size YoY Growth 2016-2027
7.2 North America Influenza NA Inhibitor Market Facts & Figures by Country
7.2.1 North America Influenza NA Inhibitor Sales by Country (2016-2021)
7.2.2 North America Influenza NA Inhibitor Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Influenza NA Inhibitor Market Size YoY Growth 2016-2027
8.2 Asia Pacific Influenza NA Inhibitor Market Facts & Figures by Region
8.2.1 Asia Pacific Influenza NA Inhibitor Sales by Region (2016-2021)
8.2.2 Asia Pacific Influenza NA Inhibitor Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Influenza NA Inhibitor Market Size YoY Growth 2016-2027
9.2 Europe Influenza NA Inhibitor Market Facts & Figures by Country
9.2.1 Europe Influenza NA Inhibitor Sales by Country (2016-2021)
9.2.2 Europe Influenza NA Inhibitor Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Influenza NA Inhibitor Market Size YoY Growth 2016-2027
10.2 Latin America Influenza NA Inhibitor Market Facts & Figures by Country
10.2.1 Latin America Influenza NA Inhibitor Sales by Country (2016-2021)
10.2.2 Latin America Influenza NA Inhibitor Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Influenza NA Inhibitor Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Influenza NA Inhibitor Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza NA Inhibitor Sales by Country (2016-2021)
11.2.2 Middle East and Africa Influenza NA Inhibitor Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Green Cross
12.1.1 Green Cross Corporation Information
12.1.2 Green Cross Description and Business Overview
12.1.3 Green Cross Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Green Cross Influenza NA Inhibitor Products Offered
12.1.5 Green Cross Recent Development
12.2 Roche
12.2.1 Roche Corporation Information
12.2.2 Roche Description and Business Overview
12.2.3 Roche Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Roche Influenza NA Inhibitor Products Offered
12.2.5 Roche Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Corporation Information
12.3.2 GlaxoSmithKline Description and Business Overview
12.3.3 GlaxoSmithKline Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GlaxoSmithKline Influenza NA Inhibitor Products Offered
12.3.5 GlaxoSmithKline Recent Development
12.4 Henan DaKen Chemical
12.4.1 Henan DaKen Chemical Corporation Information
12.4.2 Henan DaKen Chemical Description and Business Overview
12.4.3 Henan DaKen Chemical Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Henan DaKen Chemical Influenza NA Inhibitor Products Offered
12.4.5 Henan DaKen Chemical Recent Development
12.5 ATK Chemical
12.5.1 ATK Chemical Corporation Information
12.5.2 ATK Chemical Description and Business Overview
12.5.3 ATK Chemical Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
12.5.4 ATK Chemical Influenza NA Inhibitor Products Offered
12.5.5 ATK Chemical Recent Development
12.6 Chemwill Asia Co.,Ltd.
12.6.1 Chemwill Asia Co.,Ltd. Corporation Information
12.6.2 Chemwill Asia Co.,Ltd. Description and Business Overview
12.6.3 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Products Offered
12.6.5 Chemwill Asia Co.,Ltd. Recent Development
12.7 Shionogi Co.
12.7.1 Shionogi Co. Corporation Information
12.7.2 Shionogi Co. Description and Business Overview
12.7.3 Shionogi Co. Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Shionogi Co. Influenza NA Inhibitor Products Offered
12.7.5 Shionogi Co. Recent Development
12.8 NeoPharm
12.8.1 NeoPharm Corporation Information
12.8.2 NeoPharm Description and Business Overview
12.8.3 NeoPharm Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
12.8.4 NeoPharm Influenza NA Inhibitor Products Offered
12.8.5 NeoPharm Recent Development
12.9 Moksha8 Pharma
12.9.1 Moksha8 Pharma Corporation Information
12.9.2 Moksha8 Pharma Description and Business Overview
12.9.3 Moksha8 Pharma Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Moksha8 Pharma Influenza NA Inhibitor Products Offered
12.9.5 Moksha8 Pharma Recent Development
12.11 Green Cross
12.11.1 Green Cross Corporation Information
12.11.2 Green Cross Description and Business Overview
12.11.3 Green Cross Influenza NA Inhibitor Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Green Cross Influenza NA Inhibitor Products Offered
12.11.5 Green Cross Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Influenza NA Inhibitor Industry Trends
13.2 Influenza NA Inhibitor Market Drivers
13.3 Influenza NA Inhibitor Market Challenges
13.4 Influenza NA Inhibitor Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza NA Inhibitor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Influenza NA Inhibitor Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Zanamivir
Table 3. Major Manufacturers of Oseltamivir
Table 4. Major Manufacturers of Peramivir
Table 5. Global Influenza NA Inhibitor Market Size Growth Rate by Application (2021-2027) & (Kilotons)
Table 6. Global Influenza NA Inhibitor Market Size by Region (Kilotons) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Influenza NA Inhibitor Sales by Regions (2016-2021) & (Kilotons)
Table 8. Global Influenza NA Inhibitor Sales Market Share by Regions (2016-2021)
Table 9. Global Influenza NA Inhibitor Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Influenza NA Inhibitor Sales Forecast by Region (2022-2027) & (Kilotons)
Table 11. Global Influenza NA Inhibitor Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Influenza NA Inhibitor Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Influenza NA Inhibitor Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Influenza NA Inhibitor Sales by Manufacturers (2016-2021) (Kilotons)
Table 15. Global Influenza NA Inhibitor Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Influenza NA Inhibitor Manufacturers by Revenue (US$ Million) in 2020
Table 17. Influenza NA Inhibitor Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Influenza NA Inhibitor Revenue Share by Manufacturers (2016-2021)
Table 19. Global Influenza NA Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Influenza NA Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza NA Inhibitor as of 2020)
Table 21. Key Manufacturers Influenza NA Inhibitor Price (2016-2021) (US$/Kg)
Table 22. Influenza NA Inhibitor Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Influenza NA Inhibitor Product Type
Table 24. Date of International Manufacturers Enter into Influenza NA Inhibitor Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Influenza NA Inhibitor Sales by Type (2016-2021) (Kilotons)
Table 27. Global Influenza NA Inhibitor Sales Share by Type (2016-2021)
Table 28. Global Influenza NA Inhibitor Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Influenza NA Inhibitor Revenue Share by Type (2016-2021)
Table 30. Influenza NA Inhibitor Average Selling Price (ASP) by Type (2016-2021) & (US$/Kg)
Table 31. Global Influenza NA Inhibitor Sales Forecast by Type (2022-2027) & (Kilotons)
Table 32. Global Influenza NA Inhibitor Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Influenza NA Inhibitor Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Influenza NA Inhibitor Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Influenza NA Inhibitor Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Kg)
Table 36. Global Influenza NA Inhibitor Sales by Application (2016-2021) (Kilotons)
Table 37. Global Influenza NA Inhibitor Sales Share by Application (2016-2021)
Table 38. Global Influenza NA Inhibitor Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Influenza NA Inhibitor Revenue Share by Application (2016-2021)
Table 40. Influenza NA Inhibitor Average Selling Price (ASP) by Application (2016-2021) & (US$/Kg)
Table 41. Global Influenza NA Inhibitor Sales Forecast by Application (2022-2027) & (Kilotons)
Table 42. Global Influenza NA Inhibitor Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Influenza NA Inhibitor Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Influenza NA Inhibitor Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Influenza NA Inhibitor Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Kg)
Table 46. Japan Influenza NA Inhibitor Sales (Kilotons) of Key Companies (2016-2021)
Table 47. Japan Influenza NA Inhibitor Sales Share by Company (2016-2021)
Table 48. Japan Influenza NA Inhibitor Revenue (US$ Million) by Company (2016-2021)
Table 49. Japan Influenza NA Inhibitor Revenue Share by Company (2016-2021)
Table 50. Japan Influenza NA Inhibitor Sales (Kilotons) by Type (2016-2021)
Table 51. Japan Influenza NA Inhibitor Sales Share by Type (2016-2021)
Table 52. Japan Influenza NA Inhibitor Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. Japan Influenza NA Inhibitor Price (US$/Kg) by Type (2016-2021)
Table 54. Japan Influenza NA Inhibitor Sales (Kilotons) by Type (2022-2027)
Table 55. Japan Influenza NA Inhibitor Sales Share by Type (2022-2027)
Table 56. Japan Influenza NA Inhibitor Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. Japan Influenza NA Inhibitor Revenue Share by Type (2022-2027)
Table 58. Japan Influenza NA Inhibitor Price (US$/Kg) by Type (2022-2027)
Table 59. Japan Influenza NA Inhibitor Sales (Kilotons) by Application (2016-2021)
Table 60. Japan Influenza NA Inhibitor Sales Share by Application (2016-2021)
Table 61. Japan Influenza NA Inhibitor Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. Japan Influenza NA Inhibitor Price (US$/Kg) by Application (2016-2021)
Table 63. Japan Influenza NA Inhibitor Sales (Kilotons) by Application (2022-2027)
Table 64. Japan Influenza NA Inhibitor Sales Share by Application (2022-2027)
Table 65. Japan Influenza NA Inhibitor Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. Japan Influenza NA Inhibitor Revenue Share by Application (2022-2027)
Table 67. Japan Influenza NA Inhibitor Price (US$/Kg) by Application (2022-2027)
Table 68. North America Influenza NA Inhibitor Sales by Country (2016-2021) & (Kilotons)
Table 69. North America Influenza NA Inhibitor Sales Market Share by Country (2016-2021)
Table 70. North America Influenza NA Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Influenza NA Inhibitor Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Influenza NA Inhibitor Sales by Region (2016-2021) & (Kilotons)
Table 73. Asia Pacific Influenza NA Inhibitor Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Influenza NA Inhibitor Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Influenza NA Inhibitor Revenue Market Share by Region (2016-2021)
Table 76. Europe Influenza NA Inhibitor Sales by Country (2016-2021) & (Kilotons)
Table 77. Europe Influenza NA Inhibitor Sales Market Share by Country (2016-2021)
Table 78. Europe Influenza NA Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Influenza NA Inhibitor Revenue Market Share by Country (2016-2021)
Table 80. Latin America Influenza NA Inhibitor Sales by Country (2016-2021) & (Kilotons)
Table 81. Latin America Influenza NA Inhibitor Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Influenza NA Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Influenza NA Inhibitor Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Influenza NA Inhibitor Sales by Country (2016-2021) & (Kilotons)
Table 85. Middle East and Africa Influenza NA Inhibitor Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Influenza NA Inhibitor Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Influenza NA Inhibitor Revenue Market Share by Country (2016-2021)
Table 88. Green Cross Corporation Information
Table 89. Green Cross Description and Business Overview
Table 90. Green Cross Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 91. Green Cross Influenza NA Inhibitor Product
Table 92. Green Cross Recent Development
Table 93. Roche Corporation Information
Table 94. Roche Description and Business Overview
Table 95. Roche Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 96. Roche Product
Table 97. Roche Recent Development
Table 98. GlaxoSmithKline Corporation Information
Table 99. GlaxoSmithKline Description and Business Overview
Table 100. GlaxoSmithKline Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 101. GlaxoSmithKline Product
Table 102. GlaxoSmithKline Recent Development
Table 103. Henan DaKen Chemical Corporation Information
Table 104. Henan DaKen Chemical Description and Business Overview
Table 105. Henan DaKen Chemical Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 106. Henan DaKen Chemical Product
Table 107. Henan DaKen Chemical Recent Development
Table 108. ATK Chemical Corporation Information
Table 109. ATK Chemical Description and Business Overview
Table 110. ATK Chemical Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 111. ATK Chemical Product
Table 112. ATK Chemical Recent Development
Table 113. Chemwill Asia Co.,Ltd. Corporation Information
Table 114. Chemwill Asia Co.,Ltd. Description and Business Overview
Table 115. Chemwill Asia Co.,Ltd. Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 116. Chemwill Asia Co.,Ltd. Product
Table 117. Chemwill Asia Co.,Ltd. Recent Development
Table 118. Shionogi Co. Corporation Information
Table 119. Shionogi Co. Description and Business Overview
Table 120. Shionogi Co. Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 121. Shionogi Co. Product
Table 122. Shionogi Co. Recent Development
Table 123. NeoPharm Corporation Information
Table 124. NeoPharm Description and Business Overview
Table 125. NeoPharm Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 126. NeoPharm Product
Table 127. NeoPharm Recent Development
Table 128. Moksha8 Pharma Corporation Information
Table 129. Moksha8 Pharma Description and Business Overview
Table 130. Moksha8 Pharma Influenza NA Inhibitor Sales (Kilotons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2016-2021)
Table 131. Moksha8 Pharma Product
Table 132. Moksha8 Pharma Recent Development
Table 133. Influenza NA Inhibitor Market Trends
Table 134. Influenza NA Inhibitor Market Drivers
Table 135. Influenza NA Inhibitor Market Challenges
Table 136. Influenza NA Inhibitor Market Restraints
Table 137. Influenza NA Inhibitor Customers List
Table 138. Influenza NA Inhibitor Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza NA Inhibitor Product Picture
Figure 2. Global Influenza NA Inhibitor Sales Market Share by Type in 2020 & 2027
Figure 3. Zanamivir Product Picture
Figure 4. Oseltamivir Product Picture
Figure 5. Peramivir Product Picture
Figure 6. Global Influenza NA Inhibitor Sales Market Share by Application in 2020 & 2027
Figure 7. Influenza A Treatment
Figure 8. Influenza B Treatment
Figure 9. Influenza NA Inhibitor Report Years Considered
Figure 10. Global Influenza NA Inhibitor Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Influenza NA Inhibitor Market Size 2016-2027 (US$ Million)
Figure 12. Global Influenza NA Inhibitor Sales 2016-2027 (Kilotons)
Figure 13. Global Influenza NA Inhibitor Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Influenza NA Inhibitor Sales Market Share by Region (2016-2021)
Figure 15. Global Influenza NA Inhibitor Sales Market Share by Region in 2020
Figure 16. Global Influenza NA Inhibitor Revenue Market Share by Region (2016-2021)
Figure 17. Global Influenza NA Inhibitor Revenue Market Share by Region in 2020
Figure 18. Global Influenza NA Inhibitor Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Influenza NA Inhibitor Revenue in 2020
Figure 20. Influenza NA Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Influenza NA Inhibitor Sales Market Share by Type (2016-2021)
Figure 22. Global Influenza NA Inhibitor Sales Market Share by Type in 2020
Figure 23. Global Influenza NA Inhibitor Revenue Market Share by Type (2016-2021)
Figure 24. Global Influenza NA Inhibitor Revenue Market Share by Type in 2020
Figure 25. Global Influenza NA Inhibitor Sales Market Share by Application (2016-2021)
Figure 26. Global Influenza NA Inhibitor Sales Market Share by Application in 2020
Figure 27. Global Influenza NA Inhibitor Revenue Market Share by Application (2016-2021)
Figure 28. Global Influenza NA Inhibitor Revenue Market Share by Application in 2020
Figure 29. Japan Influenza NA Inhibitor Sales Growth Rate 2016-2027 (Kilotons)
Figure 30. Japan Influenza NA Inhibitor Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. Japan Influenza NA Inhibitor Market Share in Global Market 2016-2027
Figure 32. Japan 5 and 10 Largest Influenza NA Inhibitor Players Market Share by Revenue in Influenza NA Inhibitor in 2020
Figure 33. Japan Influenza NA Inhibitor Revenue Share by Type (2016-2021)
Figure 34. Japan Influenza NA Inhibitor Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Japan Influenza NA Inhibitor Revenue Share by Application (2016-2021)
Figure 36. Japan Influenza NA Inhibitor Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Influenza NA Inhibitor Sales Growth Rate 2016-2021 (Kilotons)
Figure 38. North America Influenza NA Inhibitor Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Influenza NA Inhibitor Sales Market Share by Country in 2020
Figure 40. North America Influenza NA Inhibitor Revenue Market Share by Country in 2020
Figure 41. U.S. Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 42. U.S. Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 44. Canada Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Influenza NA Inhibitor Sales Growth Rate 2016-2021 (Kilotons)
Figure 46. Europe Influenza NA Inhibitor Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Influenza NA Inhibitor Sales Market Share by Country in 2020
Figure 48. Europe Influenza NA Inhibitor Revenue Market Share by Country in 2020
Figure 49. Germany Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 50. Germany Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 52. France Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 54. U.K. Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 56. Italy Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 58. Russia Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Influenza NA Inhibitor Sales Growth Rate 2016-2021 (Kilotons)
Figure 60. Asia Pacific Influenza NA Inhibitor Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Influenza NA Inhibitor Sales Market Share by Region in 2020
Figure 62. Asia Pacific Influenza NA Inhibitor Revenue Market Share by Region in 2020
Figure 63. China Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 64. China Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 66. Japan Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 68. South Korea Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 70. India Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 72. Australia Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 74. Taiwan Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 76. Indonesia Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 78. Thailand Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 80. Malaysia Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 82. Philippines Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 84. Vietnam Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Influenza NA Inhibitor Sales Growth Rate 2016-2021 (Kilotons)
Figure 86. Latin America Influenza NA Inhibitor Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Influenza NA Inhibitor Sales Market Share by Country in 2020
Figure 88. Latin America Influenza NA Inhibitor Revenue Market Share by Country in 2020
Figure 89. Mexico Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 90. Mexico Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 92. Brazil Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 94. Argentina Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Influenza NA Inhibitor Sales Growth Rate 2016-2021 (Kilotons)
Figure 96. Middle East and Africa Influenza NA Inhibitor Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Influenza NA Inhibitor Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Influenza NA Inhibitor Revenue Market Share by Country in 2020
Figure 99. Turkey Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 100. Turkey Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 102. Saudi Arabia Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. UAE Influenza NA Inhibitor Sales Growth Rate (2016-2021) (Kilotons)
Figure 104. UAE Influenza NA Inhibitor Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Influenza NA Inhibitor Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
Industry Market Size
